Investor Presentaiton

Delivering Strong Growth and High Profitability... Billings (€m)1 +29% 82.7 +34% cc 106.4 Adj. EBITDA (Em) & Margin² +26% +34% cc 58.2 46.0 55.6% 54.7% Q3 2019 Q3 2020 Q3 2019 Q3 2020 +48% +58% +50% cc 332.1 +61% cc 189.3 224.3 119.6 9M 2019 1) Including Ubimax contributing €0.6m billings in Q3 2) Adj. EBITDA as % of Billings 10 Q3 2020 Investor Presentation 53.3% 57.0% 9M 2020 9M 2019 9M 2020 TeamViewer

View entire presentation